Literature DB >> 31954224

Prevalence of hypermobile Ehlers-Danlos syndrome in postural orthostatic tachycardia syndrome.

Amanda J Miller1, Lauren E Stiles2, Timothy Sheehan3, Rebecca Bascom4, Howard P Levy5, Clair A Francomano6, Amy C Arnold7.   

Abstract

Despite well-established clinical associations between Hypermobile Ehlers-Danlos syndrome (hEDS) and postural orthostatic tachycardia syndrome (POTS), the precise prevalence is unknown. We therefore evaluated for hEDS in 91 POTS participants using the 2017 hEDS diagnostic checklist, which has three major criteria: 1) generalized joint hypermobility (Beighton score), 2) systemic features, family history, and 3) absence of exclusion criteria. Overall, 28 out of 91 POTS participants (31%) met clinical criteria for hEDS. An additional 24% of participants had generalized joint hypermobility without meeting hEDS criteria. Identifying the prevalence of hEDS in POTS is important for understanding possible mechanisms connecting these two syndromes.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 31954224      PMCID: PMC7282488          DOI: 10.1016/j.autneu.2020.102637

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  11 in total

Review 1.  Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome Type III and Ehlers-Danlos syndrome hypermobility type): Clinical description and natural history.

Authors:  Brad Tinkle; Marco Castori; Britta Berglund; Helen Cohen; Rodney Grahame; Hanadi Kazkaz; Howard Levy
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-02-01       Impact factor: 3.908

2.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Authors:  Robert S Sheldon; Blair P Grubb; Brian Olshansky; Win-Kuang Shen; Hugh Calkins; Michele Brignole; Satish R Raj; Andrew D Krahn; Carlos A Morillo; Julian M Stewart; Richard Sutton; Paola Sandroni; Karen J Friday; Denise Tessariol Hachul; Mitchell I Cohen; Dennis H Lau; Kenneth A Mayuga; Jeffrey P Moak; Roopinder K Sandhu; Khalil Kanjwal
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

Review 3.  Measurement properties of clinical assessment methods for classifying generalized joint hypermobility-A systematic review.

Authors:  Birgit Juul-Kristensen; Karoline Schmedling; Lies Rombaut; Hans Lund; Raoul H H Engelbert
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-03       Impact factor: 3.908

4.  Ehlers-Danlos Syndrome and Postural Tachycardia Syndrome: a relationship study.

Authors:  Daniel Wallman; Janice Weinberg; Anna Depold Hohler
Journal:  J Neurol Sci       Date:  2014-03-11       Impact factor: 3.181

5.  A survey-based analysis of symptoms in patients with postural orthostatic tachycardia syndrome.

Authors:  Anindita Deb; Karen Morgenshtern; Collin J Culbertson; Liz B Wang; Anna DePold Hohler
Journal:  Proc (Bayl Univ Med Cent)       Date:  2015-04

Review 6.  Postural tachycardia syndrome and other forms of orthostatic intolerance in Ehlers-Danlos syndrome.

Authors:  Maria Roma; Colleen L Marden; Inge De Wandele; Clair A Francomano; Peter C Rowe
Journal:  Auton Neurosci       Date:  2018-03-05       Impact factor: 3.145

7.  Demographics of a large paediatric Postural Orthostatic Tachycardia Syndrome Program.

Authors:  Jeffrey R Boris; Thomas Bernadzikowski
Journal:  Cardiol Young       Date:  2018-01-23       Impact factor: 1.093

8.  The 2017 international classification of the Ehlers-Danlos syndromes.

Authors:  Fransiska Malfait; Clair Francomano; Peter Byers; John Belmont; Britta Berglund; James Black; Lara Bloom; Jessica M Bowen; Angela F Brady; Nigel P Burrows; Marco Castori; Helen Cohen; Marina Colombi; Serwet Demirdas; Julie De Backer; Anne De Paepe; Sylvie Fournel-Gigleux; Michael Frank; Neeti Ghali; Cecilia Giunta; Rodney Grahame; Alan Hakim; Xavier Jeunemaitre; Diana Johnson; Birgit Juul-Kristensen; Ines Kapferer-Seebacher; Hanadi Kazkaz; Tomoki Kosho; Mark E Lavallee; Howard Levy; Roberto Mendoza-Londono; Melanie Pepin; F Michael Pope; Eyal Reinstein; Leema Robert; Marianne Rohrbach; Lynn Sanders; Glenda J Sobey; Tim Van Damme; Anthony Vandersteen; Caroline van Mourik; Nicol Voermans; Nigel Wheeldon; Johannes Zschocke; Brad Tinkle
Journal:  Am J Med Genet C Semin Med Genet       Date:  2017-03       Impact factor: 3.908

9.  Small fiber neuropathy is a common feature of Ehlers-Danlos syndromes.

Authors:  Daniele Cazzato; Marco Castori; Raffaella Lombardi; Francesca Caravello; Eleonora Dalla Bella; Antonio Petrucci; Paola Grammatico; Chiara Dordoni; Marina Colombi; Giuseppe Lauria
Journal:  Neurology       Date:  2016-06-15       Impact factor: 9.910

10.  The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey.

Authors:  B H Shaw; L E Stiles; K Bourne; E A Green; C A Shibao; L E Okamoto; E M Garland; A Gamboa; A Diedrich; V Raj; R S Sheldon; I Biaggioni; D Robertson; S R Raj
Journal:  J Intern Med       Date:  2019-04-16       Impact factor: 8.989

View more
  12 in total

Review 1.  The challenges of chronic pain and fatigue.

Authors:  Jessica A Eccles; Kevin A Davies
Journal:  Clin Med (Lond)       Date:  2021-01       Impact factor: 2.659

2.  Orthostatic leg pain in neuropathic postural tachycardia syndrome: what does muscle excitability have to do with it?

Authors:  Amy C Arnold; Judith Navarro-Otano
Journal:  Clin Auton Res       Date:  2021-11-12       Impact factor: 4.435

3.  Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.

Authors:  Lucia Micale; Carmela Fusco; Marco Castori
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Headache and Autonomic Dysfunction: a Review.

Authors:  Courtney Iser; Karissa Arca
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-22       Impact factor: 6.030

5.  Hypermobile Ehlers-Danlos Syndrome: A Prodromal Subtype of Functional Movement Disorders?

Authors:  Jason Margolesky; Dyanet Puentes; Alberto J Espay
Journal:  Mov Disord Clin Pract       Date:  2022-08-24

6.  Symptom Presentation and Access to Medical Care in Patients With Postural Orthostatic Tachycardia Syndrome: Role of Sex.

Authors:  Kate M Bourne; Juliette Hall; Lauren E Stiles; Robert S Sheldon; Cyndya A Shibao; Luis E Okamoto; Emily M Garland; Alfredo C Gamboa; Amanda Peltier; Andre Diedrich; Italo Biaggioni; David Robertson; Satish R Raj
Journal:  CJC Open       Date:  2021-09-04

7.  Impact of Comorbidities on the Prognosis of Pediatric Postural Tachycardia Syndrome.

Authors:  Yaru Wang; Junbao Du; Xueying Li; Ping Liu; Yuli Wang; Ying Liao; Hongfang Jin
Journal:  Int J Gen Med       Date:  2021-11-27

8.  Joint Hypermobility in Paediatric Acute-Onset Neuropsychiatric Syndrome-A Preliminary Case-Control Study.

Authors:  Susanne Bejerot; Ulrika Hylén; Martin Glans; Eva Hesselmark; Mats B Humble
Journal:  Front Psychiatry       Date:  2021-12-03       Impact factor: 4.157

Review 9.  Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.

Authors:  Cortney Gensemer; Randall Burks; Steven Kautz; Daniel P Judge; Mark Lavallee; Russell A Norris
Journal:  Dev Dyn       Date:  2020-08-17       Impact factor: 3.780

10.  Postural orthostatic tachycardia syndrome (POTS): State of the science and clinical care from a 2019 National Institutes of Health Expert Consensus Meeting - Part 1.

Authors:  Steven Vernino; Kate M Bourne; Lauren E Stiles; Blair P Grubb; Artur Fedorowski; Julian M Stewart; Amy C Arnold; Laura A Pace; Jonas Axelsson; Jeffrey R Boris; Jeffrey P Moak; Brent P Goodman; Kamal R Chémali; Tae H Chung; David S Goldstein; Andre Diedrich; Mitchell G Miglis; Melissa M Cortez; Amanda J Miller; Roy Freeman; Italo Biaggioni; Peter C Rowe; Robert S Sheldon; Cyndya A Shibao; David M Systrom; Glen A Cook; Taylor A Doherty; Hasan I Abdallah; Anil Darbari; Satish R Raj
Journal:  Auton Neurosci       Date:  2021-06-05       Impact factor: 2.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.